Screening group | Study population N (%) | Lost samples N (%) | Final Study population N (%) |
---|---|---|---|
Cytology | 362 (100) | 79 (22) | 283 (78) |
VIA | 362 (100) | 0 | 362 (100) |
HPV | 362/100) | 16 (4) | 346 (96) |
Referred group | |||
 Cytology | 107 (100) | 51 (48) | 56 (52) |
 VIA | 107 (100) | 0 | 107 (100) |